On behalf of the Division of Craniofacial Medicine in the Department of Pediatrics at the University of Washington School of Medicine (UWSOM) and Seattle Children’s Hospital (SCH), CareerPhysician, LLC, the national leader in executive search and leadership development in Academic Child Health, is pleased to announce a national search initiated to identify candidates for the Medical Director of the Craniofacial Genetics Program at the rank of Clinical Assistant, Clinical Associate or Clinical Professor to provide both craniofacial pediatric and clinical genetic services.
The Craniofacial Center at Seattle Children’s Hospital specializes in the treatment of cleft lip and palate, Robin sequence, craniosynostosis, craniofacial microsomia, and many other rare and complex craniofacial conditions. The center has become one of the most comprehensive craniofacial centers in North America with a multidisciplinary craniofacial team of over 50 healthcare providers and staff from 14 specialty areas that provide all aspects of care for children with craniofacial conditions.
Opportunity Highlights:
Qualifications
The successful candidate must have an MD, or DO, or MD/PhD combined (or foreign equivalent), be board eligible or board certified in Pediatrics and Genetics and must be eligible for medical licensure in the state of Washington.
To schedule a call to discuss the role in greater detail, or if you would like to recommend an individual(s) who exemplifies the qualities we are seeking in a candidate, please contact Marcel Barbey, Vice President, CareerPhysician, LLC, c/o Jennifer Weimer at [email protected]. All interactions will remain confidential, and no inquiries will be made without the consent of the applicant.
UWSOM is an AA/EOE/ADA employer that values diversity and inclusion and is committed to building and sustaining an academic community in which teachers, researchers, and learners achieve the knowledge, skills, and attitudes that value and embrace inclusiveness, equity, and awareness to unleash creativity and innovation.